CONMED Corp.

Company Snapshot

Founded: 1970
Entity Type: Public
Employees: 3,900
Region: U.S.
Revenue: $1,307.0 Millions
Revenue Year: 2024
Headquarter: Florida, U.S.
Key Geographics: U.S., Europe, Middle East & Africa, Asia Pacific, Americas (excluding the U.S.)
Corporate Address: 11311 Concept Boulevard Largo, Florida 33773 U.S. Tel. +1-727-392-6464 www.conmed.com

Company Overview

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The company operates through two primary business segments: Orthopedic Surgery and General surgery.

The General surgery segment caters to the bronchoscopy market. General Surgery offers a wide range of advanced surgical and endoscopic technology products. Advanced endoscopic technologies include a comprehensive line of therapeutic and diagnostic products used majorly in gastroenterology. Additionally, it comprises a platform of products for pulmonology procedures.

The Company’s end users comprised surgeons and other healthcare professionals in various specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. The company sells its products in approximately 100 countries. International sales efforts are coordinated through local country dealers, sub-distributors, sales agents, or direct in-country sales. CONMED distributes its products through sales subsidiaries and branches in various countries, including Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Italy, Japan, Korea, the Netherlands, Poland, Spain, Sweden, and the United Kingdom. As of FY 2022, CONMED had around 4,100 employees.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

CONMED Corp. In Reports

Global Bronchoscopy Market

BCC Research Market Report says global bronchoscopy market should reach $3.9 billion by 2028 from $2.7 billion in 2023 at a compound annual growth rate of 7.4%.

Operating Room Equipment and Software: Global Markets

BCC Research Market Report says global market for operating room equipment and software reached $26.1 billion in 2022 and estimated to increase from $27.8 billion in 2023 to reach $38.9 billion by 2028.

Regenerative Medicines: Bone and Joint Applications

BCC Research Market Report says global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022 and estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028.

Company's Business Segments

  • Orthopedic Surgery : This segment design, manufacture, and distribute products which enable orthopedic surgeons to surgically address sports medicine injuries in the knee, hip, shoulder, and lower extremities.
  • General Surgery : This segment offers a large range of products in the areas of advanced surgical and advanced endoscopic technologies.

Applications/End User Industries

  • Healthcare
  • Medical Devices